Ray Dalio's PCVX Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 12,903 shares of Vaxcyte, Inc. (PCVX) worth $749,793, representing 0.00% of the portfolio. First purchased in 2025-Q3, this short-term holding has been held for 3 quarters.
Based on 13F filings, Ray Dalio has maintained this position in PCVX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2026, adding 12,903 shares. Largest reduction occurred in Q4 2025, reducing 11,855 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Vaxcyte (PCVX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Vaxcyte (PCVX) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +12,903 | New Buy | 12,903 | $58.11 |
| Q4 2025 | -11,855 | Sold Out | 0 | $0.00 |
| Q3 2025 | +11,855 | New Buy | 11,855 | $36.02 |
Ray Dalio's Vaxcyte Investment FAQs
Ray Dalio first purchased Vaxcyte, Inc. (PCVX) in Q3 2025, acquiring 11,855 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Vaxcyte, Inc. (PCVX) for 3 quarters since Q3 2025.
Ray Dalio's largest addition to Vaxcyte, Inc. (PCVX) was in Q1 2026, adding 12,903 shares worth $749,793.
According to the latest 13F filing for Q1 2026, Ray Dalio's firm, Bridgewater Associates, Lp, owns 12,903 shares of Vaxcyte, Inc. (PCVX), valued at approximately $749,793.
As of the Q1 2026 filing, Vaxcyte, Inc. (PCVX) represents approximately 0.00% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Vaxcyte, Inc. (PCVX) was 12,903 shares, as reported at the end of Q1 2026.